Universitätspublikationen
Refine
Year of publication
Document Type
- Article (10976)
- Preprint (1701)
- Doctoral Thesis (1575)
- Working Paper (1440)
- Part of Periodical (569)
- Conference Proceeding (513)
- Report (299)
- Part of a Book (107)
- Review (92)
- Book (60)
Language
- English (17425) (remove)
Has Fulltext
- yes (17425) (remove)
Keywords
- inflammation (95)
- COVID-19 (91)
- SARS-CoV-2 (63)
- Financial Institutions (48)
- climate change (46)
- Germany (45)
- ECB (43)
- aging (43)
- apoptosis (42)
- cancer (42)
Institute
- Medizin (5153)
- Physik (3111)
- Frankfurt Institute for Advanced Studies (FIAS) (1663)
- Wirtschaftswissenschaften (1650)
- Biowissenschaften (1412)
- Informatik (1262)
- Center for Financial Studies (CFS) (1138)
- Sustainable Architecture for Finance in Europe (SAFE) (1066)
- Biochemie und Chemie (858)
- House of Finance (HoF) (702)
- Gesellschaftswissenschaften (617)
- Geowissenschaften (580)
- Biochemie, Chemie und Pharmazie (520)
- Senckenbergische Naturforschende Gesellschaft (386)
- Institut für Ökologie, Evolution und Diversität (383)
- E-Finance Lab e.V. (346)
- Psychologie (334)
- Rechtswissenschaft (288)
- Biodiversität und Klima Forschungszentrum (BiK-F) (278)
- Exzellenzcluster Die Herausbildung normativer Ordnungen (205)
- Pharmazie (197)
- Institute for Monetary and Financial Stability (IMFS) (170)
- Exzellenzcluster Makromolekulare Komplexe (166)
- Informatik und Mathematik (166)
- Psychologie und Sportwissenschaften (166)
- Geowissenschaften / Geographie (162)
- Neuere Philologien (152)
- MPI für Hirnforschung (129)
- MPI für Biophysik (122)
- Mathematik (122)
- Georg-Speyer-Haus (111)
- Buchmann Institut für Molekulare Lebenswissenschaften (BMLS) (105)
- Sportwissenschaften (104)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (103)
- Sonderforschungsbereiche / Forschungskollegs (102)
- Ernst Strüngmann Institut (95)
- Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit (ZAFES) (90)
- Sprach- und Kulturwissenschaften (87)
- Philosophie (80)
- Präsidium (74)
- Evangelische Theologie (59)
- Kulturwissenschaften (58)
- Erziehungswissenschaften (53)
- Geographie (53)
- Foundation of Law and Finance (50)
- Deutsches Institut für Internationale Pädagogische Forschung (DIPF) (49)
- Geschichtswissenschaften (47)
- MPI für empirische Ästhetik (44)
- Institut für Sozialforschung (IFS) (41)
- Universitätsbibliothek (38)
- ELEMENTS (37)
- Institut für sozial-ökologische Forschung (ISOE) (37)
- Institute for Law and Finance (ILF) (28)
- Philosophie und Geschichtswissenschaften (24)
- Center for Membrane Proteomics (CMP) (17)
- Extern (16)
- Exzellenzcluster Herz-Lungen-System (16)
- Starker Start ins Studium: Qualitätspakt Lehre (14)
- Cornelia Goethe Centrum für Frauenstudien und die Erforschung der Geschlechterverhältnisse (CGC) (13)
- Interdisziplinäres Zentrum für Ostasienstudien (IZO) (11)
- Zentrum für Interdisziplinäre Afrikaforschung (ZIAF) (11)
- Hessische Stiftung für Friedens- und Konfliktforschung (HSFK) (10)
- LOEWE-Schwerpunkt Außergerichtliche und gerichtliche Konfliktlösung (10)
- Sprachwissenschaften (10)
- Interdisziplinäres Zentrum für Neurowissenschaften Frankfurt (IZNF) (9)
- Center for Scientific Computing (CSC) (8)
- LOEWE-Schwerpunkt für Integrative Pilzforschung (8)
- Helmholtz International Center for FAIR (7)
- DFG-Forschergruppen (6)
- Frobenius Institut (6)
- Goethe-Zentrum für Wissenschaftliches Rechnen (G-CSC) (6)
- Zentrum für Weiterbildung (6)
- Institut für Wirtschaft, Arbeit, und Kultur (IWAK) (5)
- Katholische Theologie (5)
- Hochschulrechenzentrum (4)
- Zentrum für Nordamerika-Forschung (ZENAF) (4)
- Frankfurt MathFinance Institute (FMFI) (3)
- Gleichstellungsbüro (3)
- Universität des 3. Lebensalters e.V. (3)
- Sigmund-Freud Institut – Forschungsinstitut fur Psychoanalyse und ihre Anwendungen (2)
- keine Angabe Institut (2)
- (1)
- Akademie für Bildungsforschung und Lehrerbildung (bisher: Zentrum für Lehrerbildung und Schul- und Unterrichtsforschung) (1)
- Diagnostic Center of Acute Leukemia (1)
- Europäische Akademie der Arbeit in der Universität Frankfurt am Main (1)
- Exzellenzcluster (1)
- Fachübergreifend (1)
- Fachübergreifende Einrichtungen (1)
- Forschungscluster (1)
- Institut für Bienenkunde (1)
- Wilhelm-Merton-Zentrum (1)
- keine Angabe Fachbereich (1)
- studiumdigitale (1)
The chitinase-like protein YKL-40 was found to be increased in patients with severe asthma and chronic obstructive pulmonary disease (COPD), two disease conditions featuring neutrophilic infiltrates. Based on these studies and a previous report indicating that neutrophils secrete YKL-40, we hypothesized that YKL-40 plays a key role in cystic fibrosis (CF) lung disease, a prototypic neutrophilic disease. The aim of this study was (i) to analyze YKL-40 levels in human and murine CF lung disease and (ii) to investigate whether YKL-40 single-nucleotide polymorphisms (SNPs) modulate CF lung disease severity. YKL-40 protein levels were quantified in serum and sputum supernatants from CF patients and control individuals. Levels of the murine homologue BRP-39 were analyzed in airway fluids from CF-like βENaC-Tg mice. YKL-40SNPs were analyzed in CF patients. YKL-40 levels were increased in sputum supernatants and in serum from CF patients compared to healthy control individuals. Within CF patients, YKL-40 levels were higher in sputum than in serum. BRP-39 levels were increased in airways fluids from βENaC-Tg mice compared to wild-type littermates. In both CF patients and βENaC-Tg mice, YKL-40/BRP-39 airway levels correlated with the severity of pulmonary obstruction. Two YKL-40 SNPs (rs871799 and rs880633) were found to modulate age-adjusted lung function in CF patients. YKL-40/BRP-39 levelsare increased in human and murine CF airway fluids, correlate with pulmonary function and modulate CF lung disease severity genetically. These findings suggest YKL-40 as a potential biomarker in CF lung disease.
Background
Cytochrome-P450 (CYP450) epoxygenases metabolise arachidonic acid (AA) into four different biologically active epoxyeicosatrienoic acid (EET) regioisomers. Three of the EETs (i.e., 8,9-, 11,12- and 14,15-EET) are rapidly hydrolysed by the enzyme soluble epoxide hydrolase (sEH). Here, we investigated the role of sEH in nociceptive processing during peripheral inflammation.
Results
In dorsal root ganglia (DRG), we found that sEH is expressed in medium and large diameter neurofilament 200-positive neurons. Isolated DRG-neurons from sEH-/- mice showed higher EET and lower DHET levels. Upon AA stimulation, the largest changes in EET levels occurred in culture media, indicating both that cell associated EET concentrations quickly reach saturation and EET-hydrolyzing activity mostly effects extracellular EET signaling. In vivo, DRGs from sEH-deficient mice exhibited elevated 8,9-, 11,12- and 14,15-EET-levels. Interestingly, EET levels did not increase at the site of zymosan-induced inflammation. Cellular imaging experiments revealed direct calcium flux responses to 8,9-EET in a subpopulation of nociceptors. In addition, 8,9-EET sensitized AITC-induced calcium increases in DRG neurons and AITC-induced calcitonin gene related peptide (CGRP) release from sciatic nerve axons, indicating that 8,9-EET sensitizes TRPA1-expressing neurons, which are known to contribute to mechanical hyperalgesia. Supporting this, sEH-/- mice showed increased nociceptive responses to mechanical stimulation during zymosan-induced inflammation and 8,9-EET injection reduced mechanical thresholds in naive mice.
Conclusion
Our results show that the sEH can regulate mechanical hyperalgesia during inflammation by inactivating 8,9-EET, which sensitizes TRPA1-expressing nociceptors. Therefore we suggest that influencing the CYP450 pathway, which is actually highly considered to treat cardiovascular diseases, may cause pain side effects.
The present work comprises different projects within the scope of public health. In detail, they all aim at combating the high-burden diseases HIV/AIDS, malaria and tuberculosis more effectively. Since there was, and still is, no harmonization between the existing biowaiver guidelines, the biowaiver dissolution test conditions by WHO and FDA were compared against each other using drug products, which had already demonstrated BE to the comparator in vivo. Thereby it could be shown that the dissolution conditions proposed by the WHO are more appropriate for granting biowaivers than those of the FDA. Further, the applicability of the WHO dissolution test conditions was investigated using the APIs ethambutol, isoniazid and pyrazinamide (all BCS Class III) as model compounds. These investigations demonstrated that the concept of the biowaiver proved to work properly, i.e. leading to no false positive BE decision and an acceptable incidence of false negative BE decisions. In addition, four new biowaiver monographs were published addressing important APIs in the treatment of HIV/AIDS and malaria. Before these efforts, there were only a very few biowaiver monographs available for antiviral or antimalarial APIs, i.e. the database of biowaiver monographs has been clearly improved. The last part of the present work dealt with the extension of the biowaiver concept to related areas such as the WHO Prequalification of Medicines Programme. Investigations revealed that the biowaiver tools are generally eligible for prequalification of drug products containing ethambutol, isoniazid, pyrazinamide, or lamivudine to prove BE between an appropriate comparator and the test candidate. By contrast, some APIs are excluded from the biowaiver procedure. In conclusion, the implementation of the biowaiver tools for prequalification of biowaivable APIs is, along with BCS-based biowaiver approval of new generics, an important step towards making essential, high-quality drug products more cost-effective and, as a consequence, more accessible for a larger percentage of the population. In that way, the treatment conditions for those in need living in the developing countries can be improved enormously, so that those who are poor do not have to receive poor treatment. The quality standard of essential medicines will increase worldwide, thereby helping to combat the high-burden diseases better and, in turn, lead to an improvement of the global health status.
The current work investigated the association of trait anxiety and the neural efficiency of cognitive processing for affectively neutral (not threat-related) information. In a sample of 46 healthy volunteers, three fMRI experiments were conducted to test the prediction derived from attentional control theory (Eysenck et al., 2007) that high as compared to low trait-anxious individuals expend more neural effort on tasks requiring the top-down control of attention to reach a given level of performance. In a colour-word Stroop task requiring the inhibition of irrelevant stimulus information and associated responses as well as in a working-memorymanipulation task requiring the shifting of attention between items in working memory, trait anxiety (as measured with the State-Trait Anxiety Inventory; Spielberger et al., 1970) was positively associated with task-related increases in the activation of two adjacent regions in the right dorsolateral prefrontal cortex (DLPFC). The finding that along with a stronger activation of this brain region commonly implicated in top-down control processes, the high-anxious subjects showed equal (working memory manipulation) or worse (Stroop) performance when compared to low-anxious subjects, does support the assumption that processing is less efficient in the high anxious. However, in contrast to the predictions, trait anxiety did not show a significant association with task-related brain activation in a task-switching paradigm requiring shifting between task sets. It is discussed how different attentional control demands of the task may account for differences in the effects of trait anxiety on overt behavioural performance and underlying neural processes. In addition to DLPFC activation, trait anxiety modulated the functional connectivity of distributed regions involved in processing of the Stroop and the working-memory-manipulation task. It is discussed how the observed differences in regional DLPFC activation and network connectivity relate to each other. A possible interpretation suggests that activation increases in the DLPFC reflect an attempt to compensate for suboptimal connectivity by investing more effort in prefrontally supported control processes. Overall, the current work shows an association of trait anxiety with the neural efficiency of cognitive processing in affectively neutral tasks involving attentional control. Furthermore, it suggests that investigations of neural efficiency should take into account difference in functional integration in addition to regional activation.
Time-resolved spectroscopic analysis of fucoxanthin-chlorophyll proteins and isolated carotenoids
(2011)
The aim of this thesis was to elucidate the excitation energy transfer in the fucoxanthin-chlorophyll proteins (FCPs) isolated from the diatom Cyclotella meneghiniana in detail and to clarify the role of the different pigments contained. In a first step the excited state dynamics of the free pigments were studied by means of time-resolved absorption spectroscopy. The FCPs contain three different carotenoid species. Besides the main light-harvesting carotenoid fucoxanthin (fx) the xanthophyll cycle pigments diadinoxanthin (ddx) and diatoxanthin (dtx) are found in substoichiometric amounts. Fx is contained in an unusual carotenoid-to-chlorophyll ratio of about one. In case of ddx and dtx, changing the solvent polarity showed no significant effects on the absorption spectrum and the excited state dynamics were hardly influenced. In contrast, a solvent dependence is observed in the absorption spectrum and excited state dynamics of fx. The S1 lifetime depends strongly on the solvent polarity and an additional broad excited state absorption band red shifted compared to the S1 excited state absorption appears. The occurrence of the described features can be explained with an intramolecular charge transfer state, which is stabilized in a polar environment and appears only in carotenoids with a conjugated carbonyl group. Despite its rather short excited state lifetimes of less than 200 fs (S2) and 30-60 ps (S1), fx acts as a very efficient energy donor in the FCPs. The ultrafast energy transfer dynamics of the isolated proteins FCPa and FCPb were investigated in a comprehensive study using transient absorption in the visible and NIR spectral region complemented with polarized transient absorption spectroscopy. The excitation energy transfer was not influenced significantly by changing the light conditions during the growth, which yields an altered amount of ddx and dtx. It can be concluded that the contribution of the xanthophyll cycle pigments to the energy transfer is not significant. The altered oligomerization state results in a more efficient energy transfer for the trimeric FCPa, which is also reflected in different Chl a fluorescence quantum yields. Thus, an increased quenching in the higher oligomers of FCPb can be assumed. The observed dynamics change drastically for two different excitation wavelengths λ = 500 nm and λ = 550 nm, which both lead to the population of the S2 excited state of individual carotenoids, namely blue and red absorbing fx molecules. The differing absorption maxima result from distinct microenvironments within the protein. For FCPa an additional slow time constant of 25 ps was found after excitation at 500 nm. By means of polarized transient absorption spectroscopy applied to FCPa different transition dipole moments for the S1 and the ICT state of fx could be identified. Based on the presented studies a detailed model explaining the excitation energy transfer pathways could be developed. In agreement with the faster overall transfer rate which is also evident in the anisotropy data in case of 550 nm excitation, upon excitation at 500 nm one slow transfer channel is active. It can be attributed to a blue absorbing fx not strongly associated with a Chl a molecule. Most likely excitation energy transfer takes place between the S1/ICT states of two different fx molecules before the energy is transferred to Chl a. Additional transient absorption experiments with an improved time resolution were performed to investigate the oscillations observed. These coherent effects superimposed the kinetics of isolated carotenoids as well as FCPs within the first 500 fs. The oscillations showed a very unusual damping behavior and vanished already after two oscillation periods. In case of fx, the solvent environment as well as the excitation wavelengths had an influence on the oscillations. The frequencies of the oscillations were 70-100 cm^-1 for fx in solvents with varying polarity and 50-80 cm^-1 for the FCPs. These results could further confirm the assumption that the red absorbing fx molecules are located in a more polar environment within the protein compared to the blue absorbing fx. To clarify the origin of the oscillations in more detail, further experiments with a controlled chirp of the applied pulses and comparison between different carotenoids in various solvents are required. This approach promises to give further insight in the excited state dynamics and to answer the question whether dark states are involved. Right now, the coherent excitation of the strongly coupled excited states 1Bu+ (S2) and 1Bu- resulting in electronic quantum beats and the existence of an additional short lived excited state absorption (S2-SN2) in the visible spectral region are the most reasonable explanations for the occurrence of the coherent effects in the transient absorption spectra of carotenoids.
Since combinatorial chemistry and high throughput screening have become a common technique in the drug discovery phase the number of compounds being considered has increased frequently. These structures are often characterized by high molecular weight, high lipophilicity and low solubility in aqueous and physiological media. Due to the generally poor bioavailability, new in vitro techniques were needed for screening of pharmacokinetic properties. An important parameter for these screening methods is the implementation at an early state of drug discovery phase, to find potential lead structures, before investment costs become significant. The established in vitro methods for the prediction of membrane interaction are not reliable especially for poorly soluble compounds. A new method that is fast and easy to use, requires only small amounts of NCE and which can provide more reliable predictions is needed. In this study, a new screening technique based on surface activity profiling for the prediction of oral drug absorption was evaluated with special emphasis on the predictability of biological membrane interaction of poorly soluble drug compounds. It was demonstrated that drug absorption through a bilayer membrane can be modeled by the orientation of compounds at the air/water interface. Thus amphilicity of a drug is generally related to both oral absorption and blood brain barrier penetration. In turn, amphiphilicity is influenced by the lipophilicity, size and charge distribution of a drug. Surface activity profiling was determined by analysis of surface pressure profiles using the Gibbs adsorption isotherm. The surface activity measurements were carried out using a multichannel tensiometer Delta 8, which was developed by Kibron to be utilized in conjugation high throughput screening in early drug discovery processes. For this study two test sets were analyzed, one for the prediction of gastrointestinal wall interaction and the second for the prediction of the penetration behavior at the blood brain barrier. Both test sets consist of drug compounds with a wide range of absorption properties and consist mainly of compounds with poor water solubility. Since the drugs characteristics varied, they were classified according to water solubility and surface activity and a sample preparation method for each group was established. For the prediction of oral drug absorption, three different methods were established to model the interaction of compound and gastrointestinal wall. For drug compounds with solubility above 1mmol/L the traditional shake-flask method enabled the determination of the amphiphilic properties of drug compounds in pure aqueous media. Compounds with solubility below 1mmol/L tend to not to exhibit any increase in surface activity. Thus surface tension measurements of compounds, which exhibited a limited surface activity due to poor aqueous solubility, were conducted from stock solutions prepared with various organic solvents. Mainly polar organic solvents were used. A mixture of DMSO and DMF resulted in the best combination of properties: the intensive solubility enhancing effect of DMF and the lower intrinsic surface activity of DMSO. The polar solvent ruptured the water clusters, so that highly lipophilic structures had a higher affinity to the solvent and higher concentrations could be obtained. For these compounds higher maximum surface pressure were generated than was possible in pure aqueous media. The surface pressure data were correlated with the fraction absorbed values in vivo. However it was found that poor water solubility is not the only limiting step to exhibiting any surface activity. Some compounds were showed no surface activity in either solvent system. Therefore a micelle vehicle method was established using short chain phospholipids to mimic the gastrointestinal wall. It could be concluded from the results, that non surface active drugs can interact with the phospholipids micelle vehicle in a way analogous to their interaction with the membrane bilayer. The relative critical micelle concentration was correlated with the fraction absorbed of this test set. A sample preparation schema based on the three types of drugs was established. This schema enabled us to predict the absorbance of slightly soluble and poorly soluble drugs with acceptable reliability for early compound screening. For the prediction of blood brain barrier penetration using surface activity profiling as analyzing method, a test set with very poorly soluble characteristics was chosen. The sample preparation method was based on a strictly aqueous approach using the ‘shake flask’ method. The surface tension measurements enabled correlation of the amphiphilic properties of the very poorly soluble drug compounds with BBB uptake. From the aqueous surface pressure profiles and the determination of physicochemical parameters, it was found that blood brain barrier is more likely when a drug provides a small cross-sectional area, As, at the interface. The cross-sectional area is the only parameter which is independent from the maximal concentration in aqueous media and it is particularly suitable for lower solubility compounds. In summary, it was shown that amphilicity is related to biological membrane interaction in the human body and that surface activity profiling with appropriate sample preparation can be used as a reliable screening tool for the prediction of oral drug absorption of poorly soluble drugs. Furthermore an in vitro screening method of blood-brain-barrier penetration was established.
It is the objective of this paper to determine the voting premium for French shares by comparing the values of voting and non-voting shares, and to analyze the value of the voting rights. The study uses data for 25 French companies which had both types of shares outstanding and traded on the stock exchange during the entire period from 1986 to 1996, or for some time during this interval. The average value of the voting premium is 51,35%.
The paper analyzes the reasons for this surprisingly high value by testing different hypotheses based on dividend differences, the revival) of the voting right, capitalization, shareholder structure, and the share of non-voting capital in total equity capital. The regressions show that the shareholder structure strongly influences the value of the voting premium.
A case study of the attempted takeover of Casino by Promodes shows that investors attach a much higher value to the voting right during relevant situations than at other tomes. Both companies involved had, at the time, two types of shares outstanding and listed. Furthermore the paper shows that non-voting shares have never played an important role in equity finance in France since the companies have different alternatives.
In an international cumparison, France is found to have the second highest voting premium, exceeded only by that of Italy. A probable reason is the low quality of the national accounting standards and the low level of minority shareholder protection.
This article reports on the second Young Environmental Scientists Meeting that was hosted from 28 February to 2 March 2011 by the Institute for Environmental Research at RWTH Aachen University, Germany. This extraordinary meeting was again initiated and organized by the Student Advisory Council under the umbrella of Society of Environmental Toxicology and Chemistry Europe. A movie about the meeting and the abstracts of poster and platform presentations are freely available as supplemental material of this article.
Succinctness is a natural measure for comparing the strength of different logics. Intuitively, a logic L_1 is more succinct than another logic L_2 if all properties that can be expressed in L_2 can be expressed in L_1 by formulas of (approximately) the same size, but some properties can be expressed in L_1 by (significantly) smaller formulas.
We study the succinctness of logics on linear orders. Our first theorem is concerned with the finite variable fragments of first-order logic. We prove that:
(i) Up to a polynomial factor, the 2- and the 3-variable fragments of first-order logic on linear orders have the same succinctness. (ii) The 4-variable fragment is exponentially more succinct than the 3-variable fragment. Our second main result compares the succinctness of first-order logic on linear orders with that of monadic second-order logic. We prove that the fragment of monadic second-order logic that has the same expressiveness as first-order logic on linear orders is non-elementarily more succinct than first-order logic.
Tumor hypoxia and nutrient starvation are common phenomena in cancerous tissue. Cells that resist this hostile environment are selected for a more aggressive phenotype, usually accompanied by therapy resistance. The hypoxia inducible factors HIF-1a and HIF-2a play a key role in the adaptive homeostatic responses to these challenging conditions inducing a number of target genes that are involved in the regulation of a variety of cellular processes such as angiogenesis, proliferation, metabolism, self-renewal and cell death/cycle arrest. Thus, the HIF pathway encompasses opposing adaptive responses on tumor growthgrowth promoting abilities on the one hand and growth inhibiting on the other. A recent study in our lab uncovered that this switch between cell death and cell survival critically depends on HIF-2a protein levels. Since PHDs (HIF prolyl hydroxylases) are the main regulators of HIF protein abundance and hypoxia drives the malignant phenotype of tumors, we wanted to characterize HIF regulatory functions of PHDs under hypoxic conditions. Our intention was to reveal the importance of PHD contribution to the opposing functions of HIFs under hypoxia. Characterization of PHD1-4 mRNA and protein expression levels under normoxic and hypoxic conditions in glioblastoma cell lines led to the identification of PHD2 and PHD3 as hypoxia inducible PHD isoforms and highlighted their predominant function under hypoxia. Mechanistically, we demonstrated that HIF mediates the hypoxic induction of PHD2 and 3 within a negative feedback loop, promoting its own degradation during prolonged hypoxia. The functional impact of PHD2 and 3 abundance on cell viability under hypoxic conditions was analyzed by disrupting PHD2 and PHD3 function either through a siRNA mediated approach or by application of the PHD inhibitor DMOG. These experiments uncovered that PHD2 and 3 are protective under hypoxic conditions and that PHD inhibition expedites cell death. Combined HIF and PHD suppression under hypoxic conditions abrogated this increased susceptibility to cell death, clearly showing that PHD2 and 3 act in a negative feedback regulatory loop to limit the HIF response under prolonged hypoxia. With respect to possible future therapeutical applications we co-treated cells with a PHD inhibitor and pro-apoptotic agents staurosporine or TRAIL. Co-challenging tumor cells even potentiated the cell death response, indicating a more widespread protective function of PHD. Taken together PHD2 and 3 protect tumor cells from cell death induction, functioning in a negative feedback regulatory loop to constrain the HIF dependent cell death responses under hypoxia. Interestingly, however, when assessing the role of PHD2 and PHD3 in in vivo tumor growth using an intracranial tumor model, we identified an exclusive tumor suppressor function for PHD3. Loss of PHD3 function enhanced tumor growth whereas increased PHD3 expression diminished the tumor burden. The accelerated tumor growth following PHD3 loss could be attributed to a decrease in the induction of apoptosis and an increase in proliferation. Tumor cells are frequently exposed to temporary and spatial depletion of nutrients. Interestingly, PHD3 loss conferred a growth advantage under growth factor deprivation. The growth regulatory function of PHD3 was isoform specific, HIF independent and importantly, did not require the hydroxylase function of PHD3. Previous reports have uncovered a regulatory function of the PHD system in NF-kB signaling. However, our results demonstrated that NF- kB signaling remained unaffected by alteration in the PHD3 status of the cell. Additionally, the PHD3 tumor suppressor function proved to be independent of two putative PHD3 downstream effectors, ATF4 and KIF1Bb. Mechanistically, PHD3 suppression reduced EGFR internalization, enhancing the amount of EGFR expressed on the cell surface. We further showed that the impaired EGFR internalization during PHD3 loss resulted in receptor hyperactivation under stimulated and growth factor deprived conditions. Importantly, PHD3 physcially associated with the EGFR complex as evidenced by co-immunoprecpitation. Consequently, this extended EGFR activation in PHD3 deficient cells resulted in enhanced downstream activation of EGFR signaling and increased proliferation. Consistent with the interpretation that PHD3 loss is beneficial for tumor growth, we found PHD3 promoter methylation in glioblastoma cell lines, hinting at a epigenetic mechanism to finetune PHD3 expression on top of the hypoxic driven gene regulation. Finally, we demonstrated that PHD3 tumor suppressor function is not restricted to glioblastomas since PHD3 suppression in lung adenocarcinoma accelerated subcutaneous tumor growth. With these findings, we expand the knowledge of PHD3 action from its oxygen sensing role to a regulatory function in growth factor signaling. This clearly discriminates PHD3 from the other isoforms and supports the exclusive tumor suppressor function in glioblastoma. Taken together our results identify a complex role of PHD signaling in cancer and delineate HIF dependent and HIF independent functions of the PHD system. We think that the HIF dependent protective effect of PHD2 and 3 and the HIF independent PHD3 tumor suppressor function are not mutually exclusive, but might be activated according to the heterogeneous intra-tumoral conditions. However, PHD3 hydroxylase activity is dispensable for its HIFindependent tumor suppressor function in glioma. This uncouples PHD3 function from co-factor and co-substrate requirements and allows it to act over a broader physiological range, since its influence on cellular processes is not constrained by the availability of rate limiting factors. It might explain, why the enzymatic independent functions of PHD3 predominate in vivo. Thus, therapeutic modulation of the PHD system to inhibit tumor growth has to be based on these contrasting functions of the PHD system. However, their differential dependence on the hydroxylase activity may facilitate a therapeutic strategy to specifically inhibit or promote the protective versus suppressive functions of the PHD system.